Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I1LE
|
|||
Drug Name |
US8586571, 36
|
|||
Synonyms |
SCHEMBL3105846; CHEMBL3642666; VZDYQTRPYQHMNA-UHFFFAOYSA-N; BDBM106682; US8586571, 36; 3-(3-(2-tert-butylphenoxy)azetidin-1-yl)-3-oxopropanoic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H21NO4
|
|||
Canonical SMILES |
CC(C)(C)C1=CC=CC=C1OC2CN(C2)C(=O)CC(=O)O
|
|||
InChI |
1S/C16H21NO4/c1-16(2,3)12-6-4-5-7-13(12)21-11-9-17(10-11)14(18)8-15(19)20/h4-7,11H,8-10H2,1-3H3,(H,19,20)
|
|||
InChIKey |
VZDYQTRPYQHMNA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Plasma retinol-binding protein (RBP4) | Target Info | Inhibitor | [1] |
Target's Patent Info | Plasma retinol-binding protein (RBP4) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Heterocyclic compound. US8586571. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.